In UK, new partnership, not money

Five British hospitals and medical research centers are joining forces to link basic research and healthcare more closely, the University College London (UCL) announced last week. The Guardian linkurl:reported;http://www.guardian.co.uk/society/2008/aug/07/health.highereducation?gusrc=rss&feed=politics last Thursday that the four centers "disclosed plans for a 2 billion [pound] business partnership to create the largest biomedical research organization in Europe," suggesting that new hefty fundi

Written byAndrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Five British hospitals and medical research centers are joining forces to link basic research and healthcare more closely, the University College London (UCL) announced last week. The Guardian linkurl:reported;http://www.guardian.co.uk/society/2008/aug/07/health.highereducation?gusrc=rss&feed=politics last Thursday that the four centers "disclosed plans for a 2 billion [pound] business partnership to create the largest biomedical research organization in Europe," suggesting that new hefty funding is being allocated to the project. But the new partnership, which will be called UCL Partners and support 3,500 scientists and clinicians across the UK, is receiving no new money, Neil Goodwin, UCL Partners project director, told The Scientist. Rather, the five institutions together account for nearly $3.8 billion (approximately 2 billion pounds) in annual funding and revenue. By pooling these resources and researchers at each center, Goodwin added, the hope is to better translate scientific findings into healthcare approaches. Governance under a bigger umbrella will not create more roadblocks for researchers, he said. "There are no plans to change the way organizations operate. They will remain as they are, governance is not going to merge. The intention is to keep additional bureaucracy to a minimum." Goodwin also said that there are no foreseeable changes in which centers get what money. Mostly, the partnership is about creating a global force in biomedical research.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo